Biopharmaceuticals Market Research Reports & Industry Analysis
Biopharmaceuticals Industry Research & Market Reports
-
Biosimilar Market Trends 2019
... and therapeutic equivalents of brand name drugs. However, biosimilars are not generic biologics because there can be no generic form of biologics due to the complex process of creating biologics. Biosimilar Market Trends 2019 is ... Read More
-
Biopharmaceutical Bioseparation Systems
... the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. ... Read More
-
Biopharmaceuticals – A Global Market Overview
... increase in adoption of biopharmaceuticals globally. Biopharmaceuticals offer several benefits including highly effective and potent action, fewer side effects, and the potential to actually cure diseases rather than merely treat the symptoms, which have significantly ... Read More
-
Biosimilars
... the period 2015 through 2022. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 71 companies including many ... Read More
-
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Japan
... information and analysis on the healthcare, regulatory and reimbursement landscape in Japan. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Japan. ... Read More
-
Global Biosimilars and Follow-On Biologics Market 2019-2029
... half of the forecast period. The market is dominated by Biosimilar Monoclonal Antibodies, this submarket is estimated to hold 23% share of this market in 2018. How this report will benefit you Read on to ... Read More
-
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Germany
... information and analysis on the healthcare, regulatory and reimbursement landscape in Germany. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Germany. ... Read More
-
NeuroScientific Biopharmaceuticals Ltd (NSB) - Financial and Strategic SWOT Analysis Review
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ... Read More
-
Sino Biopharmaceutical Ltd (1177) - Financial and Strategic SWOT Analysis Review
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ... Read More
-
Biosimilar Market in Europe: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024
... a value of US$ 11,663.1 Million by 2024, growing at a CAGR of 24.9% during 2019-2024. The European biosimilar market represents the most mature in the world and continues to rally momentum. This market is ... Read More
-
The 2020-2025 World Outlook for Biopharmaceuticals
... (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country ... Read More
-
The 2020-2025 World Outlook for Generic Biosimilars
... industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge ... Read More
-
The 2020-2025 World Outlook for Biosimilar Drugs
... industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge ... Read More
-
The 2020-2025 World Outlook for Artificial Tears
... industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge ... Read More
-
The 2020-2025 World Outlook for Biopharmaceutical Bioseparation Systems
... or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to ... Read More
-
The 2020-2025 World Outlook for Erythropoietin Stimulating Agents (ESA)
... latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the ... Read More
-
The 2020-2025 World Outlook for Biologic Therapeutic Drugs
... or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to ... Read More
-
The 2020-2025 World Outlook for Biosimilars and Related Biologics
... latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the ... Read More
-
The 2020-2025 World Outlook for Biosimilar Monoclonal Antibodies (mAb)
... latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the ... Read More
-
The 2020-2025 World Outlook for Biosimulation Technologies
... industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge ... Read More
-
The 2020-2025 World Outlook for Bone Graft Substitutes
... or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to ... Read More
-
The 2020-2025 World Outlook for Biosimilars
... (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country ... Read More
-
Generic and Biosimilar Pharmaceuticals (GLOBAL) - Industry Report
... analysis on the top 1310 companies, including SANOFI, SHANGHAI PHARMACEUTICALS HOLDING COMPANY LIMITED and SHIRE PLC. This report includes a wealth of information on the financial trends over the past four years. Plimsoll Publishing's latest ... Read More
-
Biopharmaceutical Companies (GLOBAL) - Industry Report
... including ABBVIE LOGISTICS B.V., BIOMARIN PHARMACEUTICAL INC and INSTITUTO GRIFOLS SA. This report includes a wealth of information on the financial trends over the past four years. Plimsoll Publishing's latest Biopharmaceutical Companies (GLOBAL) analysis is ... Read More
-
Global Biosimilars Market - Increasingly Lucrative Market Fueled by Constrained Payer Environment and Patent Expiries for Best-Selling Biologics
... Best-Selling Biologics Summary The Global Biosimilar market by product is projected to grow at a compound annual growth rate (CAGR) of 45.22%. The market is driven mainly by a constrained payer environment and patent expiration ... Read More
